CalciMedica Inc. (CALC)
CalciMedica Statistics
Share Statistics
CalciMedica has 13.48M shares outstanding. The number of shares has increased by 25.42% in one year.
| Shares Outstanding | 13.48M |
| Shares Change (YoY) | 25.42% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | 38.3% |
| Shares Floating | 6.17M |
| Failed to Deliver (FTD) Shares | 1.19K |
| FTD / Avg. Volume | 2.86% |
Short Selling Information
The latest short interest is 108.09K, so 0.8% of the outstanding shares have been sold short.
| Short Interest | 108.09K |
| Short % of Shares Out | 0.8% |
| Short % of Float | 1.27% |
| Short Ratio (days to cover) | 4.39 |
Valuation Ratios
The PE ratio is -2905.88 and the forward PE ratio is -0.83. CalciMedica's PEG ratio is 29.06.
| PE Ratio | -2905.88 |
| Forward PE | -0.83 |
| PS Ratio | 0 |
| Forward PS | 0.2 |
| PB Ratio | 2762.7 |
| P/FCF Ratio | -1881.94 |
| PEG Ratio | 29.06 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for CalciMedica.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.34, with a Debt / Equity ratio of 0.
| Current Ratio | 5.34 |
| Quick Ratio | 5.34 |
| Debt / Equity | 0 |
| Debt / EBITDA | 0 |
| Debt / FCF | 0 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $0 |
| Profits Per Employee | $-978.57K |
| Employee Count | 14 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -72.34% in the last 52 weeks. The beta is 1.11, so CalciMedica's price volatility has been higher than the market average.
| Beta | 1.11 |
| 52-Week Price Change | -72.34% |
| 50-Day Moving Average | 1.96 |
| 200-Day Moving Average | 3.28 |
| Relative Strength Index (RSI) | 31.89 |
| Average Volume (20 Days) | 41.72K |
Income Statement
| Revenue | n/a |
| Gross Profit | 0 |
| Operating Income | -24.2M |
| Net Income | -13.7M |
| EBITDA | -24.2M |
| EBIT | n/a |
| Earnings Per Share (EPS) | 0 |
Balance Sheet
The company has 7.93M in cash and 0 in debt, giving a net cash position of 7.93M.
| Cash & Cash Equivalents | 7.93M |
| Total Debt | 0 |
| Net Cash | 7.93M |
| Retained Earnings | -159.76M |
| Total Assets | 19.79M |
| Working Capital | 15.98M |
Cash Flow
In the last 12 months, operating cash flow was -21.15M and capital expenditures -8K, giving a free cash flow of -21.15M.
| Operating Cash Flow | -21.15M |
| Capital Expenditures | -8K |
| Free Cash Flow | -21.15M |
| FCF Per Share | 0 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CALC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for CALC is $16, which is 952.6% higher than the current price. The consensus rating is "Buy".
| Price Target | $16 |
| Price Target Difference | 952.6% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
Stock Splits
The last stock split was on Mar 20, 2023. It was a backward split with a ratio of 1:14.
| Last Split Date | Mar 20, 2023 |
| Split Type | backward |
| Split Ratio | 1:14 |
Scores
| Altman Z-Score | -12.1 |
| Piotroski F-Score | 1 |